Concepts (32)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2019 | 21 | 0.320 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2019 | 46 | 0.310 |
Why?
|
| Sulfonamides | 2 | 2019 | 126 | 0.300 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2025 | 85 | 0.220 |
Why?
|
| Oncologists | 1 | 2023 | 19 | 0.210 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2025 | 169 | 0.210 |
Why?
|
| Hodgkin Disease | 1 | 2023 | 56 | 0.210 |
Why?
|
| Immunoconjugates | 1 | 2023 | 89 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2025 | 185 | 0.200 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 389 | 0.200 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2019 | 3 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 648 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 142 | 0.140 |
Why?
|
| Mutation | 1 | 2025 | 2549 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 699 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 281 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 5334 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 322 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 14043 | 0.050 |
Why?
|
| Prognosis | 1 | 2025 | 1687 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 102 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 626 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 821 | 0.030 |
Why?
|
| Patient Safety | 1 | 2019 | 242 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 16361 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 17079 | 0.030 |
Why?
|
| Humans | 4 | 2025 | 61707 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4538 | 0.030 |
Why?
|
| Male | 2 | 2025 | 28947 | 0.020 |
Why?
|
| Female | 2 | 2025 | 31953 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5497 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6399 | 0.020 |
Why?
|